Wolverine Trading, LLC Immunic, Inc. Transaction History

Wolverine Trading, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$0.97 - $1.6 $10,597 - $17,480	10,925 New	10,925 $16,000
Q2 2023 Aug 23, 2023	BUY	$1.33 - $2.51 $24,139 - $45,556	18,150 New	18,150 $45,000
Q2 2022 Aug 15, 2022	SELL	$3.13 - $12.25 $35,854 - $140,323	-11,455 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.54 - $14.26 $10,637 - $15,899	1,115 Added 10.78%	11,455 $132,000
Q4 2021 Feb 14, 2022	BUY	$7.34 - $10.25 $75,895 - $105,985	10,340 New	10,340 $99,000

57.6M

600

254K

Ticker IMUX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 30,565,000
Market Cap $33.9M
Description
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and oth...

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Wolverine Trading, LLC with notifications on news.